Next Article in Journal
An In Vivo Predictive Dissolution Methodology (iPD Methodology) with a BCS Class IIb Drug Can Predict the In Vivo Bioequivalence Results: Etoricoxib Products
Next Article in Special Issue
Ileo-Colon Targeting of the Poorly Water-Soluble Drug Celecoxib Using a pH-Dependent Coating in Combination with Self-Emulsifying Drug Delivery or Solid Dispersion Systems
Previous Article in Journal
Assessment and Development of the Antifungal Agent Caspofungin for Aerosolized Pulmonary Delivery
Previous Article in Special Issue
PEGylated Nanographene Oxide in Combination with Near-Infrared Laser Irradiation as a Smart Nanocarrier in Colon Cancer Targeted Therapy
 
 
Article

Article Versions Notes

Pharmaceutics 2021, 13(4), 506; https://doi.org/10.3390/pharmaceutics13040506
Action Date Notes Link
article xml file uploaded 7 April 2021 11:47 CEST Original file -
article xml uploaded. 7 April 2021 11:47 CEST Update -
article pdf uploaded. 7 April 2021 11:47 CEST Version of Record https://www.mdpi.com/1999-4923/13/4/506/pdf-vor
article html file updated 7 April 2021 11:49 CEST Original file -
article xml file uploaded 8 April 2021 09:40 CEST Update -
article xml uploaded. 8 April 2021 09:40 CEST Update https://www.mdpi.com/1999-4923/13/4/506/xml
article pdf uploaded. 8 April 2021 09:40 CEST Updated version of record https://www.mdpi.com/1999-4923/13/4/506/pdf
article html file updated 8 April 2021 09:42 CEST Update -
article html file updated 11 April 2021 12:25 CEST Update -
article html file updated 4 August 2021 13:06 CEST Update -
article html file updated 25 July 2022 11:05 CEST Update https://www.mdpi.com/1999-4923/13/4/506/html
Back to TopTop